Estimating the optimal cutoff for the IGT‐AD Distress subscale adapted for amyloid PET results disclosure by Dianxu Ren, Kim Jeong Eun, Joshua D. Grill, Jennifer H. Lingler

Get full text

Impacts of informant replacement in two industry‐sponsored Alzheimer's disease clinical trials by Mikaela K. Nishida, Michelle M. Nuño, Joshua D. Grill, Daniel L. Gillen

Get full text

Impact of study partner replacement in a mild cognitive impairment clinical trial by Lucy A. Dolmadjian, Mary Ryan Baumann, Joshua D. Grill, Daniel L. Gillen

Get full text

Effectiveness of a local recruitment registry in older adults in Southern California by Adam I. Birnbaum, Adrijana Gombosev, Zion T. Grant-Freeman, Dan Hoang, Daniel L. Gillen, Joshua D. Grill

Get full text

Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer’s disease by Gabriel L Ketron, Felix Grun, Joshua D Grill, Howard H Feldman, Robert A Rissman, Gregory J Brewer

Get full text